Home › Non-Hodgkin Lymphoma › New Jersey
Non-Hodgkin Lymphoma clinical trials in New Jersey
13 studies for Non-Hodgkin Lymphoma are looking for participants at sites in New Jersey.
Cities in New Jersey
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- Astera Cancer Care ( Site 2732), East Brunswick
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 2704), Hackensack
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT04728893A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07101328A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
- Clinical Trial Site, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06393738Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- John Theurer Cancer Center Hackensack University Medical Center, Hackensack
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent only), Middletown
- Memorial Sloan Kettering Bergen (Consent Only), Montvale
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07249528A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- Hackensack, Hackensack
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT07188558A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Hackensack University Medical Center, Hackensack
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545SynKIR-310 for Relapsed/Refractory B-NHL
- Rutgers Cancer Institute, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT06544265Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Englewood Hospital and Medical Center, Englewood
- CentraState Medical Center, Freehold
- Hackettstown Medical Center, Hackettstown
- and 5 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 17, 2026 · NCT06418204Study of SGR-1505 in Mature B-Cell Neoplasms
- Regional Cancer Care Associates, Hackensack
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT05544019SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Brunswick
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
- Hackensack University Medical Center, Hackensack
RecruitingObservational study
All ages · All sexes · Updated Oct 22, 2025 · NCT02848274Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Hackensack University Medical Center, Hackensack
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Dec 20, 2024 · NCT05967416From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.